Table 7D.
Effect of FS on Overall Performance at Baseline, Week 4, Week 8 and Week 12 of Treatment
| Valid N | Median | Minimum | Maximum | Wilcoxon Signed Ranks | p-value | |
|---|---|---|---|---|---|---|
| Overall Performance Baseline | 43 | 5.00 | 4.00 | 7.00 | 3.75 | 0.0002** |
| Overall Performance Week 4 | 48 | 6.00 | 5.00 | 8.00 | ||
| Overall Performance Baseline | 43 | 5.00 | 4.00 | 7.00 | 5.35 | 0.0001** |
| Overall Performance Week 8 | 48 | 7.00 | 5.00 | 8.00 | ||
| Overall Performance Baseline | 43 | 5.00 | 4.00 | 7.00 | 5.71 | 0.0002** |
| Overall Performance Week 12 | 47 | 8.00 | 6.00 | 9.00 |
**Significant improvement